Publication | Closed Access

A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers.

VaccinationVaccine DevelopmentPlacebo-controlled Dose-response StudyHealthy VolunteersImmunologyCold-adapted Recombinant A/victoria/3/75VirologyVaccine EfficacyInfluenza VaccineMedicineEgg-based Vaccine ProductionInfluenza Vaccines